The DOI matches its Crossref record; 483 of the 483 references it cites were found in a registry or an index.
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Open accessAbstract
BACKGROUND: Omega-3 polyunsaturated fatty acids from oily fish (long-chain omega-3 (LCn3)), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)), as well as from plants (alpha-linolenic acid (ALA)) may benefit cardiovascular health. Guidelines recommend increasing omega-3-rich foods, and sometimes supplementation, but recent trials have not confirmed this. OBJECTIVES: To assess the effects of increased intake of fish- and plant-based omega-3 fats for all-cause mortality, cardiovascular events, adiposity and lipids. SEARCH METHODS: We searched CENTRAL, MEDLINE and Embase to February 2019, plus ClinicalTrials.gov and World Health Organization International Clinical Trials Registry to August 2019, with no language restrictions. We handsearched systematic review references and bibliographies and contacted trial authors. SELECTION CRITERIA: We included randomised controlled trials (RCTs) that lasted at least 12 months and compared supplementation or advice to increase LCn3 or ALA intake, or both, versus usual or lower intake. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for inclusion, extracted data and assessed validity. We performed separate random-effects meta-analysis for ALA and LCn3 interventions, and assessed dose-response relationships through meta-regression. MAIN RESULTS: We included 86 RCTs (162,796 participants) in this review update and found that 28 were at low summary risk of bias. Trials were of 12 to 88 months' duration and included adults at varying cardiovascular risk, mainly in high-income countries. Most trials assessed LCn3 supplementation with capsules, but some used LCn3- or ALA-rich or enriched foods or dietary advice compared to placebo or usual diet. LCn3 doses ranged from 0.5 g a day to more than 5 g a day (19 RCTs gave at least 3 g LCn3 daily). Meta-analysis and sensitivity analyses suggested little or no effect of increasing LCn3 on all-cause mortality (risk ratio (RR) 0.97, 95% confidence interval (CI) 0.93 to 1.01; 143,693 participants; 11,297 deaths in 45 RCTs; high-certainty evidence), cardiovascular mortality (RR 0.92, 95% CI 0.86 to 0.99; 117,837 participants; 5658 deaths in 29 RCTs; moderate-certainty evidence), cardiovascular events (RR 0.96, 95% CI 0.92 to 1.01; 140,482 participants; 17,619 people experienced events in 43 RCTs; high-certainty evidence), stroke (RR 1.02, 95% CI 0.94 to 1.12; 138,888 participants; 2850 strokes in 31 RCTs; moderate-certainty evidence) or arrhythmia (RR 0.99, 95% CI 0.92 to 1.06; 77,990 participants; 4586 people experienced arrhythmia in 30 RCTs; low-certainty evidence). Increasing LCn3 may slightly reduce coronary heart disease mortality (number needed to treat for an additional beneficial outcome (NNTB) 334, RR 0.90, 95% CI 0.81 to 1.00; 127,378 participants; 3598 coronary heart disease deaths in 24 RCTs, low-certainty evidence) and coronary heart disease events (NNTB 167, RR 0.91, 95% CI 0.85 to 0.97; 134,116 participants; 8791 people experienced coronary heart disease events in 32 RCTs, low-certainty evidence). Overall, effects did not differ by trial duration or LCn3 dose in pre-planned subgrouping or meta-regression. There is little evidence of effects of eating fish. Increasing ALA intake probably makes little or no difference to all-cause mortality (RR 1.01, 95% CI 0.84 to 1.20; 19,327 participants; 459 deaths in 5 RCTs, moderate-certainty evidence),cardiovascular mortality (RR 0.96, 95% CI 0.74 to 1.25; 18,619 participants; 219 cardiovascular deaths in 4 RCTs; moderate-certainty evidence), coronary heart disease mortality (RR 0.95, 95% CI 0.72 to 1.26; 18,353 participants; 193 coronary heart disease deaths in 3 RCTs; moderate-certainty evidence) and coronary heart disease events (RR 1.00, 95% CI 0.82 to 1.22; 19,061 participants; 397 coronary heart disease events in 4 RCTs; low-certainty evidence). However, increased ALA may slightly reduce risk of cardiovascular disease events (NNTB 500, RR 0.95, 95% CI 0.83 to 1.07; but RR 0.91, 95% CI 0.79 to 1.04 in RCTs at low summary risk of bias; 19,327 participants; 884 cardiovascular disease events in 5 RCTs; low-certainty evidence), and probably slightly reduces risk of arrhythmia (NNTB 91, RR 0.73, 95% CI 0.55 to 0.97; 4912 participants; 173 events in 2 RCTs; moderate-certainty evidence). Effects on stroke are unclear. Increasing LCn3 and ALA had little or no effect on serious adverse events, adiposity, lipids and blood pressure, except increasing LCn3 reduced triglycerides by ˜15% in a dose-dependent way (high-certainty evidence). AUTHORS' CONCLUSIONS: This is the most extensive systematic assessment of effects of omega-3 fats on cardiovascular health to date. Moderate- and low-certainty evidence suggests that increasing LCn3 slightly reduces risk of coronary heart disease mortality and events, and reduces serum triglycerides (evidence mainly from supplement trials). Increasing ALA slightly reduces risk of cardiovascular events and arrhythm
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 483
Ghio, S., Scelsi, L., Latini, R., Masson, S., Eleuteri, E., Palvarini, M., Vriz, O., Pasotti, M., Gorini, M., Marchioli, R., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq172 · Cited by 92
Ezaki, O., Takahashi, M. M., Shigematsu, T., SHIMAMURA, K., Kimura, J., EZAKI, H., & Gotoh, T. (1999) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.45.759 · Cited by 92
Fish oil in lupus nephritis: Clinical findings and methodological implications
Clark, W. F., Parbtani, A., Naylor, C. D., Levinton, C. M., Muirhead, N., Spanner, E. D., Huff, M. W., Philbrick, D. J., & Holub, B. J. (1993) · Kidney International · doi:10.1038/ki.1993.215 · Cited by 91
Enns, J. E., Yeganeh, A., Zarychanski, R., Abou-Setta, A. M., Friesen, C., Zahradka, P. C., & Taylor, C. G. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-70 · Cited by 91
Leng, G. C., Lee, A. J., Fowkes, F. G. R., Jepson, R. G., Lowe, G. D. O., SKINNER, E. R., & Mowat, B. (1998) · Clinical Nutrition · doi:10.1016/s0261-5614(98)80318-x · Cited by 90
Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics
Asbell, P. A., Maguire, M. G., Peskin, E., Bunya, V. Y., & Kuklinski, E. J. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.06.002 · Cited by 89
Bemelmans, W. J., Lefrandt, J., Feskens, E., Broer, J., Tervaert, J., May, J., & Smit, A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00747-x · Cited by 88
Saynor, R., & Gillott, T. (1992) · Lipids · doi:10.1007/bf02536136 · Cited by 88
Nosaka, K., Miyoshi, T., Iwamoto, M., Kajiya, M., Okawa, K., Tsukuda, S., Yokohama, F., Sogo, M., Nishibe, T., Matsuo, N., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.105 · Cited by 88
Natvig, H., Borchgrevink, C. F., Dedichen, J., OWREN, P. A., Schiøtz, E. H., & Westlund, K. (1968) · PubMed · Cited by 87
Bordeleau, L. J., Yakubovich, N., Dagenais, G. R., Rosenstock, J., Probstfield, J. L., Yu, P. C., Rydén, L., Pīrāgs, V., Spinas, G. A., Birkeland, K. I., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1468 · Cited by 86
Mortensen, M. B., & Nordestgaard, B. G. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3665 · Cited by 86
Pasternak, R. C., Brown, L. E., Stone, P. H., Silverman, D. I., Gibson, C. M., Sacks, F. M., & Harvard Atherosclerosis Reversibility Project (HARP) Study Group (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00001 · Cited by 85
Update on the Vitamin D and OmegA-3 trial (VITAL)
Pradhan, A. D., & Manson, J. E. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.04.006 · Cited by 83
La Rovere, M. T., Pinna, G. D., Maestri, R., Barlera, S., Bernardinangeli, M., Veniani, M., Nicolosi, G. L., Marchioli, R., Tavazzi, L., & for the GISSI-HF Investigators (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs126 · Cited by 82
Berendsen, A., Santoro, A., Pini, E., Cevenini, E., Ostan, R., Pietruszka, B., Rolf, K., Cano, N., Caille, A., Lyon-Belgy, N., et al. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.10.002 · Cited by 82
Holman, R. R., Paul, S., Farmer, A., Tucker, L., Stratton, I. M., Neil, H. A. W., & on behalf of the AFORRD study group (2009) · Diabetologia · doi:10.1007/s00125-008-1179-5 · Cited by 81
Chang, C. L., & Deckelbaum, R. J. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283616364 · Cited by 81
Eritsland, J., Arnesen, H., Seljeflot, I., & Høstmark, A. T. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.4.831 · Cited by 80
Rajaram, S., Valls‐Pedret, C., Cofán, M., Sabaté, J., Serra‐Mir, M., Pérez-Heras, A., Aréchiga, A. E., Casaroli-Marano, R. P., Alforja, S., Sala‐Vila, A., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00333 · Cited by 79
Rock, C. L., Flatt, S. W., Pakiz, B., Quintana, E. L., Heath, D. D., Rana, B. K., & Natarajan, L. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.008 · Cited by 78
Flaxseed in Lupus Nephritis: A Two-Year Nonplacebo-Controlled Crossover Study
Clark, W. F., Kortas, C., Heidenheim, A. P., Garland, J. S., Spanner, E. D., & Parbtani, A. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719026 · Cited by 77
Middleton, S. J., Naylor, S. J., Woolner, J. T., & Hunter, J. O. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01286.x · Cited by 77
Bhatnagar, D., & Durrington, P. N. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10490.x · Cited by 77
the PUFAH Group, Abdelhamid, A. S., Hooper, L., Sivakaran, R., Hayhoe, R. P. G., & Welch, A. A. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00584-3 · Cited by 77
Self-citationHauck, W. W., GILLISS, C. L., Donner, A. P., & Gortner, S. R. (1991) · Nursing Research · doi:10.1097/00006199-199111000-00007 · Cited by 75
Biochemical and clinical effects of an antioxidative supplementation of geriatric patients
Clausen, J., Nielsen, S. A., & Kristensen, M. (1989) · Biological Trace Element Research · doi:10.1007/bf02919106 · Cited by 74
Siero, F. W. (2000) · Health Education Research · doi:10.1093/her/15.5.635 · Cited by 74
Burr, M. L., SWEETNAM, P. M., & FEHILEY, A. M. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060645 · Cited by 73
Trøseid, M., Arnesen, H., Hjerkinn, E. M., & Seljeflot, I. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.031 · Cited by 73
Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis
Larsson, S. C., Orsini, N., & Wolk, A. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9748-9 · Cited by 73
Masson, S., Marchioli, R., Mozaffarian, D., Bernasconi, R., Milani, V., Dragani, L. K., Tacconi, M. T., Marfisi, R. M., Borgese, L., Cirrincione, V., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2012.10.021 · Cited by 73
Kumar, S., Sutherland, F., Morton, J. B., Lee, G., Morgan, J., Wong, J., Eccleston, D. E., Voukelatos, J., Garg, M. L., & SPARKS, P. B. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.11.034 · Cited by 72
Bhatia, L. S., Scorletti, E., Curzen, N. P., Clough, G. F., Calder, P. C., & Byrne, C. D. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.12.028 · Cited by 72
Caligiuri, S. P. B., Rodriguez–Leyva, D., Aukema, H. M., Ravandi, A., Weighell, W., Guzman, R., & Pierce, G. N. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07834 · Cited by 72
Grundt, H., Nilsen, D. W. T., Mansoor, M. A., Hetland, Ø., & Nordøy, A. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000073852 · Cited by 70
Diet and reinfarction trial (DART): design, recruitment, and compliance
Burr, M. L., Fehily, M., Rogers, S., WELSBY, E., KING, S., & SANDHAM, S. (1989) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059528 · Cited by 70
Leyva, D. R., Zahradka, P. C., Ramjiawan, B., Guzman, R., Aliani, M., & Pierce, G. N. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.05.005 · Cited by 69
Hodson, L., Bhatia, L. S., Scorletti, E., Smith, D. E., Jackson, N. C., Shojaee‐Moradie, F., Umpleby, A. M., Calder, P. C., & Byrne, C. D. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.9 · Cited by 69
Carrié, I., van Kan, G. A., Guyonnet, S., Andrieu, S., Dartigues, J.-F., Touchon, J., DANTOINE, T. F., Rouaud, O., Bonnefoy, M., Robert, P. H., et al. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0046-8 · Cited by 68
Berstad, P. M., SELJEFLOT, I., Veierød, M. B., Hjerkinn, E. M., Arnesen, H., & Pedersen, J. I. (2003) · Clinical Science · doi:10.1042/cs20020349 · Cited by 68
Derosa, G., Cicero, A. F. G., D’Angelo, A., Borghi, C., & Maffioli, P. (2016) · BioFactors · doi:10.1002/biof.1277 · Cited by 67
on behalf of the MooDFOOD Prevention Trial Investigators, Roca, M., Kohls, E., Gili, M., Watkins, E. R., Owens, M., Hegerl, U., van Grootheest, G., Bot, M., Cabout, M., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0900-z · Cited by 67
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial
Røysland, R., Masson, S., Omland, T., Milani, V., Bjerre, M., Flyvbjerg, A., Tano, G. D., Misuraca, G., Maggioni, A. P., Tognoni, G., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.05.015 · Cited by 66
Garbagnati, F., Cairella, G., Martino, A. D., Multari, M., Scognamiglio, U., Venturiero, V., & Paolucci, S. (2009) · Cerebrovascular Diseases · doi:10.1159/000207441 · Cited by 66
Nye, E. R., Ablett, M. B., Robertson, M. C., Ilsley, C. D. J., & Sutherland, W. H. F. (1990) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1990.tb01311.x · Cited by 66
Okuda, Y., Mizutani, M., Ogawa, M., Sone, H., Asano, M., Asakura, Y., Isaka, M., Suzuki, S., Kawakami, Y., Field, J. B., et al. (1996) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(95)00081-x · Cited by 66
Giltay, E. J., Geleijnse, J. M., & Kromhout, D. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.018259 · Cited by 66
The Effect of Fish-Oil Dietary Supplement on the Progression of Mesangial IgA Glomerulonephritis
Cheng, I. K. P., Chan, P. C. K., & Chan, M. K. (1990) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/5.4.241 · Cited by 66
Effect of Omega-3 Fatty Acids on Kidney Function after Myocardial Infarction: The Alpha Omega Trial
Hoogeveen, E. K., Geleijnse, J. M., Kromhout, D., Stijnen, T., Gemen, E. F. A., Kusters, R., & Giltay, E. J. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10441013 · Cited by 66
ORIGIN Trial Investigators (2015) · Diabetes Care · doi:10.2337/dc15-1676 · Cited by 66
Leren, P. (1968) · Europe PMC (PubMed Central) · Cited by 65
Shimizu, H., Ohtani, K.-I., Tanaka, Y., Sato, N., Mori, M., & Shimomura, Y. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01056-j · Cited by 65
Le, T., Flatt, S. W., Natarajan, L., Pakiz, B., Quintana, E. L., Heath, D. D., Rana, B. K., & Rock, C. L. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002771 · Cited by 65
Omega-3 fatty acids for intermittent claudication
Campbell, A., Price, J. F., & Hiatt, W. R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003833.pub4 · Cited by 64
Associations of alpha-linolenic acid and linoleic acid with risk factors for coronary heart disease
Bemelmans, W. J. E., Muskiet, F., Feskens, E. J. M., de Vries, J., Broer, J., May, J. F., & Jong, B. M. (2000) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601102 · Cited by 64
Fish oil supplements for prevention of restenosis after coronary angioplasty
Kaul, U., Sanghvi, S., Bahl, V. K., Dev, V., & Wasir, H. S. (1992) · International Journal of Cardiology · doi:10.1016/0167-5273(92)90059-c · Cited by 63
Ishikawa, Y., Yokoyama, M., Saitō, Y., Matsuzaki, M., Origasa, H., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., Kita, T., et al. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0520 · Cited by 63
Grundt, H., Nilsen, D. W. T., Mansoor, M. A., & Nordøy, A. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601730 · Cited by 63
n‐3 fatty acids decrease colonic epithelial cell proliferation in high‐risk bowel mucosa
Huang, Y., Jessup, J. M., Forse, R. A., Flickner, S., Pleskow, D. K., Anastopoulos, H. T., Ritter, V., & Blackburn, G. L. (1996) · Lipids · doi:10.1007/bf02637099 · Cited by 63
Expression of concern: Indo-Mediterranean Diet Heart Study
Horton, R. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67006-7 · Cited by 63
Canepa, M., Temporelli, P. L., Rossi, A., Rossi, A., Gonzini, L., Nicolosi, G. L., Staszewsky, L. I., Marchioli, R., Maggioni, A. P., Tavazzi, L., et al. (2016) · Cardiology · doi:10.1159/000448166 · Cited by 63
Pella, D., Dubnov, G., Singh, R. B., Sharma, R., Berry, E. M., & Manor, O. (2003) · KARGER eBooks · doi:10.1159/000073793 · Cited by 62
Effects of four doses of n-3 fatty acids given to hyperlipidemic patients for six months.
Harris, W. S., Windsor, S. L., & Dujovne, C. A. (1991) · Journal of the American College of Nutrition · doi:10.1080/07315724.1991.10718148 · Cited by 61
Control of bias in dietary trial to prevent coronary recurrences: The Lyon diet heart study
de Lorgeril, M., Salen, P., Caillat-Vallet, E., Mt, H., Barthélemy, J., & MAMELLE, N. (1997) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600374 · Cited by 60
Secondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel
Burr, M. L. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005241 · Cited by 60
(7667861), H. G., (7635416), S. Y., (13576753), M. R., (13337451), L. R., & (5748038), J. B. (2024) · Figshare · Cited by 60
Bourdon, J. A., Bazinet, T. M., Arnason, T., Kimpe, L. E., Blais, J. M., & White, P. A. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.07.051 · Cited by 59
Fish Oil in Diabetic Nephropathy
Rossing, P. R., Hansen, B. V., Nielsen, F. S., Myrup, B., Hølmer, G., & Parving, H. (1996) · Diabetes Care · doi:10.2337/diacare.19.11.1214 · Cited by 59
Finzi, A., Latini, R., Barlera, S., Rossi, M. G., Ruggeri, A., Mezzani, A., Favero, C., Franzosi, M. G., Serra, D., Lucci, D., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.10.032 · Cited by 57
Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction
Franzosi, M. G., Brunetti, M., Marchioli, R., Marfisi, R. M., Tognoni, G., & Valagussa, F. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119040-00008 · Cited by 56
Franzen, D., Schannwell, M., Oette, K., & Höpp, H. (1993) · Catheterization and Cardiovascular Diagnosis · doi:10.1002/ccd.1810280407 · Cited by 56
Bemelmans, W. J. E., Broer, J., de Vries, J. H. M., Hulshof, K. F. A. M., May, J. F., & Jong, B. M. (2000) · Public Health Nutrition · doi:10.1017/s1368980000000318 · Cited by 56
LeBoff, M. S., Yue, A. Y., Copeland, T., Cook, N. R., Buring, J. E., & Manson, J. E. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.01.007 · Cited by 55
Danthiir, V., Burns, N. R., Nettelbeck, T., Wilson, C. J., & Wittert, G. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-117 · Cited by 55
A long‐term seal‐ and cod‐liver‐oil supplementation in hypercholesterolemic subjects
Brox, J. H., Olaussen, K., Østerud, B., Elvevoll, E. O., Bjørnstad, E., Brenn, T., Brattebø, G., & Iversen, H. (2001) · Lipids · doi:10.1007/s11745-001-0661-4 · Cited by 54
Vitamin D and the heart: Why we need large-scale clinical trials
Manson, J. E. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77gr.10004 · Cited by 54
AlSaleh, A. F. F., Maniou, Z., Lewis, F. J., Hall, W. L., Sanders, T. A. B., & O’Dell, S. D. (2014) · Journal of Nutrition · doi:10.3945/jn.113.185108 · Cited by 54
Hashimoto, M., Kato, S., Tanabe, Y., Katakura, M., Mamun, A. A., Ohno, M., Hossain, S., Onoda, K., Yamaguchi, S., & Shido, O. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12691 · Cited by 54
Huang, L. L. H., Coleman, H. R., Kim, J., de Monasterio, F. M., Wong, W. T., Schleicher, R. L., Ferris, F. L., & Chew, E. Y. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1420 · Cited by 53
Scorletti, E., Bhatia, L. S., McCormick, K. G., Clough, G. F., Nash, K. L., Calder, P. C., & Byrne, C. D. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.02.002 · Cited by 53
Doi, M., Nosaka, K., Miyoshi, T., Iwamoto, M., Kajiya, M., Okawa, K., Nakayama, R., Takagi, W., Takeda, K., Hirohata, S., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.055 · Cited by 53
Elajami, T. K., Alfaddagh, A., Lakshminarayan, D., Soliman, M. Y., Chandnani, M., & Welty, F. K. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004740 · Cited by 53
Arnold, C., Winter, L., Fröhlich, K., Jentsch, S., Dawczynski, J., Jahreis, G., & Böhm, V. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.2851 · Cited by 52
Khoueiry, G., Rafeh, N. A., Sullivan, E., Saiful, F. B., Jaffery, Z., Kenigsberg, D. N., Krishnan, S., Khanal, S., Bekheit, S., & Kowalski, M. (2013) · Heart & Lung · doi:10.1016/j.hrtlng.2013.03.006 · Cited by 52
Gold, D. R., Litonjua, A. A., Carey, V. J., Manson, J. E., Buring, J. E., Lee, I.-M. M., Gordon, D., Walter, J. N., Friedenberg, G., Hankinson, J., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.01.003 · Cited by 52
Berendsen, A. A. M., Santoro, A., Pini, E., Cevenini, E., Ostan, R., Pietruszka, B., Rolf, K., Cano, N., Caillé, A., Lyon-Belgy, N., et al. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.03.001 · Cited by 52
Lonn, E., Bosch, J., Díaz, R., López-Jaramillo, P. A., Ramachandran, A., Hâncu, N., Hanefeld, M., Krum, H., Rydén, L., Smith, S. L., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2129 · Cited by 51
Pahor, M., Anton, S. D., Beavers, D. P., Cauley, J. A., Fielding, R. A., Kritchevsky, S. B., Leeuwenburgh, C., Lewis, K. H., Liu, C. K., Lovato, L. C., et al. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly277 · Cited by 50
Advice to eat fish and mood: a randomised controlled trial in men with angina
Ness, A. R., Gallacher, J. E. J., Bennett, P. D., Gunnell, D. J., Rogers, P. J., Kessler, D., & Burr, M. L. (2003) · Nutritional Neuroscience · doi:10.1080/1028415021000056069 · Cited by 50
Antiarrhythmic effects of n-3 fatty acids: evidence from human studies
Geelen, A., Brouwer, I. A., Zock, P. L., & Katan, M. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200402000-00006 · Cited by 50
Visual Acuity after Cataract Surgery in Patients with Age-Related Macular Degeneration
Huynh, N., Nicholson, B. P., Agrón, E., Clemons, T. E., Bressler, S. B., Rosenfeld, P. J., & Chew, E. Y. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.12.035 · Cited by 50
Rauch, B. H., Schiele, R., Schneider, S., Gohlke, H., Diller, F., Gottwik, M. G., Steinbeck, G., Heer, T., Katus, H. A., Zimmer, R., et al. (2006) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-006-0495-6 · Cited by 49
Hansen, G., Nielsen, L., Kluger, E., Thysen, M. H., Emmertsen, H., Stengaard‐Pedersen, K., Hansen, E., Unger, B., & Andersen, P. W. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609104066 · Cited by 49
Signori, C., DuBrock, C., Richie, J. P., Prokopczyk, B., Demers, L. M., Hamilton, C., Hartman, T. J., Liao, J., El‐Bayoumy, K., & Manni, A. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.60 · Cited by 49
Dangour, A. D., Clemens, F., Elbourne, D. R., Fasey, N., FLETCHER, A. E., Hardy, P., Holder, G. E., Huppert, F. A., Knight, R., Letley, L. H., et al. (2006) · Nutrition Journal · doi:10.1186/1475-2891-5-20 · Cited by 49
Kesse-Guyot, E., Péneau, S., Ferry, M., Jeandel, C., Hercberg, S., & Galan, P. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-011-0023-7 · Cited by 48
Seven-Year Incidence of Hypertension in a Cohort of Middle-Aged African Americans and Whites
He, J., Klag, M. J., Appel, L. J., Charleston, J. B., & Whelton, P. K. (1998) · Hypertension · doi:10.1161/01.hyp.31.5.1130 · Cited by 48
Andreeva, V. A., Galan, P., Torres, M. J., Julia, C., Herçberg, S., & Kesse‐Guyot, E. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.035253 · Cited by 48
Galan, P., de Bree, A., Mennen, L. I., de Courcy, G. P., Preziozi, P., Bertrais, S., Castetbon, K., & Herçberg, S. (2003) · PubMed · Cited by 48
Danthiir, V., Hosking, D. E., Burns, N. R., Wilson, C. J., Nettelbeck, T., Calvaresi, E., Clifton, P. M., & Wittert, G. (2013) · Journal of Nutrition · doi:10.3945/jn.113.175695 · Cited by 48
Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review
Balk, E. M., Adam, G. P., Langberg, V., Halladay, C., Chung, M., Lin, L., Robertson, S., Yip, A., Steele, D., Smith, B. T., et al. (2016) · doi:10.23970/ahrqepcerta223 · Cited by 47
Wheaton, D. H., Hoffman, D. R., Locke, K. G., Watkins, R. B., & Birch, D. G. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.9.1269 · Cited by 46
Aleksova, A., Masson, S., Maggioni, A. P., Lucci, D., Fabbri, G., Beretta, L., Mos, L., Paino, A. M., Nicolosi, G. L., Marchioli, R., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft103 · Cited by 46
Omega-3 Fatty Acid Supplementation in Clinical and Experimental Lupus Nephritis
Clark, W. F., & Parbtani, A. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70273-1 · Cited by 45
Fonollá-Joya, J., Reyes‐García, R., García‐Martin, A., López‐Huertas, E., & Muñoz‐Torres, M. (2016) · Journal of the American College of Nutrition · doi:10.1080/07315724.2014.1003114 · Cited by 44
Bitok, E., Jaceldo‐Siegl, K., Rajaram, S., Serra‐Mir, M., Roth, I., Freitas-Simoes, T. M., Ros, E., & Sabaté, J. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517001957 · Cited by 44
Brouwer, I. A., Zock, P. L., WEVER, E. F. D., Hauer, R. N. W., Camm, A. J., Böcker, D., Otto-Terlouw, P. C., Katan, M., & Schouten, E. G. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601695 · Cited by 43
Hull, M. A., Sandell, A. C., Montgomery, A. A., Logan, R. F., Clifford, G. M., Rees, C. J., Loadman, P. M., & Whitham, D. (2013) · Trials · doi:10.1186/1745-6215-14-237 · Cited by 43
Roig-Revert, M. J., Lleó-Pérez, A., Zanón‐Moreno, V., Vivar-Llopis, B., Marín-Montiel, J., Dolz‐Marco, R., Muñoz, L. A., Albert-Fort, M., Gálvez, M. I. L., Galarreta, D., et al. (2015) · BioMed Research International · doi:10.1155/2015/408180 · Cited by 43
He, Z., Yang, L., Tian, J., Yang, K., Wu, J., & Yao, Y. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.03.019 · Cited by 42
Ahluwalia, N., Blacher, J., de Edelenyi, F. S., Faure, P., Julia, C., Herçberg, S., & Galan, P. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.017 · Cited by 42
Hogg, R. J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90445-x · Cited by 42
Cardiovascular effects of B-vitamins and/or N-3 fatty acids: The Su.Fol.Om3 trial
Blacher, J., Czernichow, S., Paillard, F., Ducimetière, P., Herçberg, S., & Galan, P. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.060 · Cited by 42
Galan, P., Briançon, S., Blacher, J., Czernichow, S., & Herçberg, S. (2008) · Trials · doi:10.1186/1745-6215-9-35 · Cited by 41
Long-term effects of n-3 fatty acids on serum lipids and glycaemic control
Eritsland, J., Seljeflot, I., Abdelnoor, M., Arnesen, H., & Torjesen, P. A. (1994) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519409087522 · Cited by 41
Berthoux, F. C., Guérin, C., Burgard, G., Berthoux, P., & Alamartine, É. (1992) · PubMed · Cited by 41
AlSaleh, A. F. F., Crepostnaia, D., Maniou, Z., Lewis, F. J., Hall, W. L., Sanders, T. A. B., & O’Dell, S. D. (2013) · Journal of Nutrition · doi:10.3945/jn.112.172585 · Cited by 40
Andreeva (2012) · doi:10.1001/archinternmed.2011.1450 · Cited by 40
Marchioli, R., Levantesi, G., Silletta, M. G., Barlera, S., Bernardinangeli, M., Carbonieri, E., Cosmi, F., Franzosi, M. G., Latini, R., Lucci, D., et al. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.70 · Cited by 40
Levine, K. E., Levine, M. A., Weber, F. X., Hu, Y., Perlmutter, J. M., & Grohse, P. M. (2005) · Journal of Analytical Methods in Chemistry · doi:10.1155/jammc.2005.211 · Cited by 39
Fonollá, J., López‐Huertas, E., Machado, F. J., Molina, D., Álvarez, I., Mármol, E., Navas, M., Palacín, E., García-Valls, M. J., Remón, B., et al. (2008) · Nutrition · doi:10.1016/j.nut.2008.10.008 · Cited by 39
Fatty acid profile of plasma NEFA does not reflect adipose tissue fatty acid profile
Walker, C. G., Browning, L. M., Stecher, L., West, A. L., Madden, J., Jebb, S. A., & Calder, P. C. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002251 · Cited by 38
FEHILY, A. M., Vaughan‐Williams, E., Shiels, K. M., Williams, A. H., Horner, M., Bingham, G., Burr, M. L., & Holliday, R. M. (1989) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.1989.tb00026.x · Cited by 38
Borchgrevink, C., Berg, K. J., Skaga, E., Skjaeggestad, O., & Stormorken, H. (1965) · The Lancet · doi:10.1016/s0140-6736(65)92842-4 · Cited by 37
Sabour, H., Norouzi‐Javidan, A., Latifi, S., Shidfar, F., Heshmat, R., Razavi, S.-H. E., Vafa, M., & Larijani, B. A. (2014) · Journal of Spinal Cord Medicine · doi:10.1179/2045772314y.0000000251 · Cited by 37
von Schacky, C., Baumann, K., & Angerer, P. (2001) · Lipids · doi:10.1007/s11745-001-0689-5 · Cited by 37
Reed, G. W., Leung, K., Rossetti, R. G., VanBuskirk, S., Sharp, J. T., & Zurier, R. B. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/857456 · Cited by 37
Sacks, F. M., Hebert, P., Appel, L. J., Borhani, N. O., Applegate, W. B., Cohen, J., Cutler, J. A., Kirchner, K. A., Kuller, L. H., & Roth, K. J. (1994) · PubMed · Cited by 36
Griffin, B. A., Minihane, A. M., Furlonger, N., Chapman, C. M. L., Murphy, M. C., WILLIAMS, D., Wright, J. R., & Williams, C. M. (1999) · Clinical Science · doi:10.1042/cs0970269 · Cited by 36
Origasa, H., Yokoyama, M., Matsuzaki, M., Saitō, Y., Matsuzawa, Y., & The JELIS Investigators (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0746 · Cited by 36
Tapsell, L. C., Batterham, M. J., Charlton, K. E., Neale, E. P., Probst, Y., O’Shea, J. E., Thorne, R., Zhang, Q., & Louie, J. C. Y. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1231 · Cited by 36
Barreto, P. D. S., Rolland, Y., Cesari, M., Dupuy, C., Andrieu, S., Vellas, B. J., & for the MAPT study group (2017) · Age and Ageing · doi:10.1093/ageing/afx164 · Cited by 36
Baldassarre, D., Amato, M., Eligini, S., Barbieri, S. S., Mussoni, L., Frigerio, B., Kozàkovà, M., Tremoli, E., Sirtori, C. R., & Colli, S. (2006) · Annals of Medicine · doi:10.1080/07853890600852880 · Cited by 35
Is Fish Oil Good or Bad for Heart Disease? Two Trials with Apparently Conflicting Results
Burr, M. L., Dunstan, F., & George, C. H. (2005) · The Journal of Membrane Biology · doi:10.1007/s00232-005-0784-1 · Cited by 35
Sandhu, N., Schetter, S. E., Liao, J., Hartman, T. J., Richie, J. P., McGinley, J. N., Thompson, H. J., Prokopczyk, B., DuBrock, C., Signori, C., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0235 · Cited by 35
Tatsuno, I., Saitō, Y., Kudou, K., & Ootake, J. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.09.002 · Cited by 34
Hoogeveen, E. K., Geleijnse, J. M., Kromhout, D., & Giltay, E. J. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313494295 · Cited by 34
Byrne, C. D., & Targher, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.016 · Cited by 34
de Bree, A., Mennen, L. I., Herçberg, S., & Galan, P. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601871 · Cited by 33
Pedersen, J. I., Hjerkinn, E. M., Arnesen, H., Veierød, M. B., Ellingsen, I., Seljeflot, I., & Lindman, A. S. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-12-0773 · Cited by 33
Inter-pregnancy folate and iron status of women in an inner-city population
Doyle, W., Srivastava, A., Crawford, M. A., Bhatti, R., Brooke, Z., & Costeloe, K. (2001) · British Journal Of Nutrition · doi:10.1079/bjn2001376 · Cited by 33
Eritsland, J., Arnesen, H., Berg, K., Seljeflot, I., & Abdelnoor, M. (1995) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519509104966 · Cited by 33
Brügger‐Andersen, T., Hetland, Ø., Grundt, H., Nilsen, D. W. T., & Aarsetøy, H. (2006) · Thrombosis and Haemostasis · doi:10.1160/th05-07-0497 · Cited by 33
Puri, B. K., Bydder, G., Manku, M. S., Clarke, A., Waldman, A. D., & Beckmann, C. F. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600505 · Cited by 33
Marine Fish Oils: Role in Prevention of Coronary Artery Disease
Ballard-Barbash, R. R., & Callaway, C. W. (1987) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61879-5 · Cited by 33
Maachi, K., Berthoux, P., Burgard, G., Alamartine, É., & Berthoux, F. C. (1995) · PubMed · Cited by 33
Effects of Eicosapentaenoic Acid on Urinary Calcium Excretion in Calcium Stone Formers
Yasui, T., Tanaka, H., Fujita, K., Iguchi, M., & Kohri, K. (2001) · European Urology · doi:10.1159/000052507 · Cited by 32
Implications of Chronic Kidney Disease for Dietary Treatment in Cardiovascular Disease
Packard, D. P., Milton, J. E., Shuler, L. A., Short, R., & Tuttle, K. R. (2006) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.04.022 · Cited by 32
Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis
Proudman, S., Cleland, L. G., Metcalf, R. G., Sullivan, T., Spargo, L. D., & James, M. J. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002718 · Cited by 32
Özaydın, M., Erdoğan, D., Tayyar, Ş., Uysal, B. A., Doğan, A., İçli, A., Özkan, E., Varol, E., Türker, Y., & Arslan, A. (2011) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2011.080 · Cited by 31
Norouzi‐Javidan, A., Sabour, H., Latifi, S., Abrishamkar, M., Soltani, Z. E., Shidfar, F., & Razavi, H. E. (2014) · Spinal Cord · doi:10.1038/sc.2014.30 · Cited by 31
Laake, K., Myhre, P. L., Nordby, L. M., Seljeflot, I., Abdelnoor, M., Smith, P., Tveit, A., Arnesen, H., & Solheim, S. (2014) · BMC Geriatrics · doi:10.1186/1471-2318-14-74 · Cited by 31
Fish Oil to Prevent Intimal Hyperplasia and Access Thrombosis
Diskin, C. J., Thomas, C. E., Zellner, C. P., Lock, S., & Tanja, J. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000186022 · Cited by 31
Rovere, M. T. L., Staszewsky, L. I., Barlera, S., Maestri, R., Mezzani, A., Midi, P., Marchioli, R., Maggioni, A. P., Tognoni, G., Tavazzi, L., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.10.035 · Cited by 31
Marchioli, R. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90126-9 · Cited by 31
Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine
Eid, H. M. A., Arnesen, H., Hjerkinn, E. M., Lyberg, T., Ellingsen, I., & Seljeflot, I. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-4 · Cited by 30
Blood pressure variability: cardiovascular risk integrator or independent risk factor?
Blacher, J., Safar, M. E., Ly, C., de Edelenyi, F. S., Herçberg, S., & Galan, P. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2014.44 · Cited by 30
Einvik, G., Ekeberg, Ø., Lavik, J. G., Ellingsen, I., Klemsdal, T. O., & Hjerkinn, E. M. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.11.004 · Cited by 30
Merle, B. M. J., Richard, F., Benlian, P., Puche, N., Delcourt, C., & Souied, E. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130816 · Cited by 29
Treatment of Rheumatoid Arthritis with Marine and Botanical Oils: Influence on Serum Lipids
Olendzki, B. C., Leung, K., Buskirk, S. V., Reed, G., & Zurier, R. B. (2011) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2011/827286 · Cited by 29
Mansel, R. E., Harrison, B. J., Melhuish, J., SHERIDAN, W., Pye, J. K., Pritchard, G. A., Maddox, P. R., Webster, D. J. T., & Hughes, L. E. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17819.x · Cited by 29
N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease.
Cappelli, P., Liberato, L. D., Stuard, S., Ballone, E., & Albertazzi, A. (1997) · PubMed · Cited by 29
Busnach, G., Stragliotto, E., Minetti, E., Perego, A. F., Brando, B., Broggi, M. L., & Civati, G. (1998) · PubMed · Cited by 29
The results of the GISSI-Prevenzione trial in the general framework of secondary prevention
Marchioli, R., & Valagussa, F. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1971 · Cited by 28
Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD
de Edelenyi, F. S., Vergnaud, A., Ahluwalia, N., Julia, C., Herçberg, S., Blacher, J., & Galan, P. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003692 · Cited by 28
Macchia, A., Varini, S. D., Grancelli, H., Nul, D. R., Laffaye, N., Ferrante, D., Tognoni, G., & Doval, H. C. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.10.027 · Cited by 28
Manini, T. M., Anton, S. D., Beavers, D. P., Cauley, J. A., Espeland, M. A., Fielding, R. A., Kritchevsky, S. B., Leeuwenburgh, C., Lewis, K. H., Liu, C. K., et al. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14965 · Cited by 28
Chen, J. S., Hill, C. L., Lester, S. E., Ruediger, C. D., Battersby, R., Jones, G., Cleland, L. G., & MARCH, L. M. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3438-x · Cited by 27
Bowman, G. L., Silbert, L. C., Dodge, H. H., Lahna, D. L., Hagen, K., Murchison, C., Howieson, D. B., Kaye, J. A., Quinn, J. F., & Shinto, L. H. (2019) · Nutrients · doi:10.3390/nu11040735 · Cited by 27
Grundt, H., Nilsen, D. W. T., Hetland, Ø., & Mansoor, M. A. (2003) · Clinical Nutrition · doi:10.1016/j.clnu.2003.09.005 · Cited by 26
Cowie, M., Cure, S., Bianic, F., McGuire, A. J., Goodall, G., & Tavazzi, L. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr023 · Cited by 26
Eicosapentaenoic Acid Effect on Hyperlipidemia in Menopausal Japanese Women
Kurabayashi, T., OKADA, M., & TANAKA, K. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)00988-1 · Cited by 26
Querques, G., Merle, B. M. J., Pumariega, N. M., Benlian, P., Delcourt, C., Zourdani, A., Leisy, H. B., Lee, M. D., Smith, R. T., & Souied, E. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149219 · Cited by 26
Zimmer, R., Riemer, T., Rauch, B., Schneider, S., Schiele, R., Gohlke, H., Diller, F., Steinbeck, G., Katus, H., Senges, J., et al. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08453 · Cited by 25
Trøseid, M., Seljeflot, I., Weiss, T. W., Klemsdal, T. O., Hjerkinn, E. M., & Arnesen, H. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.028 · Cited by 25
Ellingsen, I., Hjerkinn, E. M., Arnesen, H., Seljeflot, I., Hjermann, I., & Tonstad, S. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602327 · Cited by 25
Furenes, E. B., Seljeflot, I., Solheim, S., Hjerkinn, E. M., & Arnesen, H. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701663350 · Cited by 25
Neil, H. A. W., Ceglarek, U., Thiery, J., Paul, S. K., Farmer, A. A., & Holman, R. R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.09.013 · Cited by 25
Ness, A., Ashfield-Watt, P. A. L., WHITING, J. M., Smith, G. D., Hughes, J., & Burr, M. L. (2004) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2004.00506.x · Cited by 25
Rischio and Prevenzione Investigators (2010) · Trials · doi:10.1186/1745-6215-11-68 · Cited by 24
Giltay, E. J., Geleijnse, J. M., Heijboer, A. C., de Goede, J., Griep, L. M. O., Blankenstein, M. A., & Kromhout, D. (2012) · International Journal of Andrology · doi:10.1111/j.1365-2605.2012.01255.x · Cited by 24
Myrup, B., Rossing, P. R., Jensen, T., Parving, H.-H., Hølmer, G., Gram, J., Kluft, C., & Jespersen, J. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655101316911387 · Cited by 24
Fougère, B., Barreto, P. D. S., Goisser, S., Soriano, G., Guyonnet, S., Andrieu, S., Vellas, B., Vellas, B. J., Guyonnet, S., Carrié, I., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.04.005 · Cited by 24
Sacks, F. M., Hebert, P. R., Appel, L. J., Borhani, N. O., Applegate, W. B., Cohen, J. D., Cutler, J. A., Kirchner, K. A., Kuller, L. H., Roth, K. J., et al. (1994) · Journal of Hypertension · doi:10.1097/00004872-199402000-00014 · Cited by 24
Ness, A., Whitley, E., Burr, M. L., Elwood, P., Smith, G., & Ebrahim, S. B. J. (1999) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000913 · Cited by 23
Ahn, J., Park, S. K., Park, T. S., Kim, J. H., Yun, E., Kim, S.-P., Lee, H. W., Oh, J., Choi, J. H., Cha, K. S., et al. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.4.481 · Cited by 23
Fezeu, L., Laporte, F., Kesse‐Guyot, E., Andreeva, V. A., Blacher, J., Herçberg, S., & Galan, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092548 · Cited by 22
Tokudome, S., Kuriki, K., Yokoyama, Y., Sasaki, M., Joh, T., Kamiya, T., Cheng, J., Ogawa, K., Shirai, T., Imaeda, N., et al. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.09.001 · Cited by 22
Clinical safety evaluation of marine oil derived from Calanus finmarchicus
Tande, K. S., Vo, T. D., & Lynch, B. S. (2016) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2016.05.030 · Cited by 22
Deslypere, J. P. (1992) · PubMed · Cited by 22
Effect of fish oil on glutathione redox system in multiple sclerosis.
Sorto-Gomez, T. E., Ortíz, G. G., Pacheco-Moisés, F. P., Torres-Sánchez, E. D., Ramírez-Ramírez, V., Macías-Islas, M. Á., de la Rosa, A. C., & Velázquez-Brizuela, I. E. (2016) · Europe PMC (PubMed Central) · Cited by 22
Ong, A. C. M., Handler, C. E., & Slater, J. D. H. (1990) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059712 · Cited by 21
Andreeva, V. A., Latarche, C., Herçberg, S., Briançon, S., Galan, P., & Kesse‐Guyot, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084844 · Cited by 21
Zheng, T., Zhao, J., Wang, Y., Liu, W., Wang, Z., Shang, Y., Zhang, W., Zhang, Y., & Zhong, M. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.11.025 · Cited by 21
Trikalinos, T. A., Moorthy, D., Chung, M., Yu, W. W., Lee, J., Lichtenstein, A. H., & Lau, J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.07.006 · Cited by 21
Marchioli, R., & Di Pasquale, A. (1993) · PubMed · Cited by 21
McCormick, K. G., Scorletti, E., Bhatia, L. S., Calder, P. C., Griffin, M. J., Clough, G. F., & Byrne, C. D. (2015) · Diabetologia · doi:10.1007/s00125-015-3628-2 · Cited by 20
Is there a role for long-chain ω3 or oil-rich fish in the treatment of atrial fibrillation?
Harrison, R. A., & Elton, P. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.06.016 · Cited by 20
Long-term influence of omega-3 fatty acids on fibrinolysis, fibrinogen, and serum lipids
Eritsland, J., Seljeflot, I., Abdelnoor, M., & Arnesen, H. (1994) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(05)80029-3 · Cited by 20
Research works printed but not linked: 83
- Geleijnse, 2011, Effects of n-3 fatty acids on cognitive decline: a randomized double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 1, S512, 10.1016/j.jalz.2011.05.1432 · DOI
- Brouwer, 2013, Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial, PLOS ONE, 8, e81519, 10.1371/journal.pone.0081519 · DOI
- Eussen, 2012, Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction, European Heart Journal, 33, 1582, 10.1093/eurheartj/ehr499 · DOI
- Geleijnse, 2011, Effects of n-3 fatty acids on cognitive decline: A randomized double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 1, S512, 10.1016/j.jalz.2011.05.1432 · DOI
- Geleijnse, 2012, Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 8, 278, 10.1016/j.jalz.2011.06.002 · DOI
- Geleijnse, 2010, Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial, American Heart Journal, 159, 539, 10.1016/j.ahj.2009.12.033 · DOI
- Giltay, 2012, No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial, International Journal of Andrology, 35, 680, 10.1111/j.1365-2605.2012.01255.x · DOI
- Giltay, 2011, Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction, American Journal of Clinical Nutrition, 94, 1442, 10.3945/ajcn.111.018259 · DOI
- Hoogeveen, 2012, Effects of N-3 fatty acids on decline of kidney function after myocardial infarction: Alpha Omega Trial, Nephrology Dialysis Transplantation, 27, ii64
- Hoogeveen, 2014, No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial, European Journal of Preventive Cardiology, 21, 1429, 10.1177/2047487313494295 · DOI
- Hoogeveen, 2014, Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial, Clinical Journal of The American Society of Nephrology: CJASN, 9, 1676, 10.2215/CJN.10441013 · DOI
- Kromhout, 2011, N-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in post myocardial infarction patients with diabetes, Diabetes Care, 34, 2515, 10.2337/dc11-0896 · DOI
- Kromhout, 2010, N-3 fatty acids and cardiovascular events after myocardial infarction, New England Journal of Medicine, 363, 2015, 10.1056/NEJMoa1003603 · DOI · Paper page
- Burr, 1989, Fish and the heart, Lancet, ii, 1451
- Harrison, 2005, Dietary Intervention for Maintaining Sinus Rhythm Following Cardioversion for Atrial Fibrillation: a Randomised Controlled Trial [PhD thesis]
- Harrison, 2003, Using community-based dietary assistants to increase the intake of oil-rich fish among older people, European Journal of Public Health, 13, 105
- Doi, 2014, Clinical outcomes of early initiation of pure eicosapentaenoic acid supplement after percutaneous coronary intervention in patients with acute coronary syndrome, European Heart Journal, 35, 1156
- Feagan, 2008, Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC randomized controlled trials, JAMA, 229, 1690, 10.1001/jama.299.14.1690 · DOI · Paper page
- Erdogan, 2007, Omega AF study: polyunsaturated fatty acids (PUFA) for prevention of atrial fibrillation relapse after successful external cardioversion, Heart Rhythm, 4, S185
- Edel, 2013, Flaxseed lignan metabolites elicit antihypertensive effects in pad patients in the flax-pad trial, Annals of Nutrition and Metabolism, 63, 1339
- Pierce, 2014, The use of dietary flaxseed to promote cardiovascular health, Acta Physiologica, 211, 15
- Pierce, 2013, The clinical use of flaxseed as a powerful nutritional intervention to treat cardiovascular disease, Cardiology (Switzerland), 126, 201
- Gill, 2014, Omega-3 fatty acids effects on carotid IMT in metabolic syndrome, Circulation, 130, A1269. Abstract
- Finzi, 2009, Antiarrhythmic effects of n-3 PUFA in patients with heart failure and an implantable cardioverter defibrillator in the GISSI-HF trial, European Heart Journal, 30, 279
- Rovere, 2011, Effect of n-3PUFA on heart rate variability. Data from the GISSI-HF holter substudy, Circulation, 124, A14829
- Latini, 2011, Circulating levels of n-3 polyunsaturated fatty acids in patients with chronic heart failure. Data from the GISSI-HF trial, European Heart Journal, 32, 919
- Marchioli, 2009, Time course analysis of the effect of n-3 PUFA on fatal and non fatal arrhythmias in heart failure: secondary results of the GISSI-HF trial, European Heart Journal, 30, 165
- Marchioli, 2009, Time course analysis of the effect of n-3 PUFA on fatal and non fatal heart failure: secondary results of the GISSI-HF trial, European Heart Journal, 30, 432
- Marchioli, 2009, Prognostic ability of a Mediterranean dietary score in heart failure: preliminary analysis of the GISSI-Heart failure Trial, European Heart Journal, 30, 1026
- Marchioli, 2009, Effect of n-3 PUFA in heart failure patients with different dietary habits: preliminary results of the GISSI-heart failure trial, European Heart Journal, 30, 426
- Marchioli, 2009, Effect of n-3 PUFA according to fish intake: preliminary results of GISSI-Heart Failure, European Heart Journal, 30, 707
- Tan, 2010, Dietary Manipulation and Weight Management [PhD thesis]
- Delrieu, 2011, Multidomain alzheimer's disease preventive trial: florbetapir ancillary study, Alzheimer's and Dementia, 1, S419, 10.1016/j.jalz.2011.05.1217 · DOI
- Gillette, 2009, The multidomain Alzheimer preventive trial (MAPT): a new approach for the prevention of Alzheimer's disease, Alzheimer's & Dementia, S4-02-05, 145, 10.1016/j.jalz.2009.05.496 · DOI
- Gillette-Guyonnet, 2011, MAPT study: a 3-year randomized trial of omega 3 and/or multidomain intervention for the prevention of cognitive decline in frail elderly subjects-rationale, design and baseline data, Alzheimer's & Dementia, 1, S97
- Vellas, 2012, MAPT (multidomain Alzheimer preventive trial) imaging (MRI, FDG-PET, amyloid-PET) data, Journal of Nutrition, Health and Aging, 16, 812
- Pinto, 2015, Effect of low doses of long chain n-3 PUFA intake on daytime heart rate variability: results from the MARINA study, European Journal of Preventive Cardiology, 1, S146
- Nodari, 2010, Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in heart failure patients, European Heart Journal, 31, 850
- Nodari, 2012, Plasma levels of n-3 polyunsaturated fatty acids and risk of hospitalization in patients with non-ischemic cardiomyopathy, Circulation. Conference: American Heart Association, 126, A17431
- Ilsey, 1987, Randomised placebo controlled trial of MAXEPA and aspirin/persantin after successful coronary angioplasty, Australian & New Zealand Journal of Medicine, 17, 559
- Naesgaard, 2014, The effect on vitamin D levels of long-term high-dose treatment with a concentrated omega-3 compound (Omacor/Lovaza) in patients hospitalized with a myocardial infarction, Circulation, 130, A17245
- Poenitz, 2012, Pentraxin 3 is uninfluenced by high doses of concentrated omega-3 fatty acids administered for 12 months following an acute myocardial infarction, Circulation. Conference: American Heart Association, 126, A13464
- Bordeleau, 2013, Cancer outcomes in patients with dysglycemia on basal insulin: results of the Origin trial, Diabetes, 62, A72
- Proudman, 2012, Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose, Internal Medicine Journal, 42, 2
- Eritsland, 1994, Effect of supplementation with n-3 fatty acids on graft patency in patients undergoing coronary artery bypass operation. Results from SHOT study, European Heart Journal, 15, 29
- Eritsland, 1993, Long-term influence of omega-3 fatty acids on fibrinolysis, fibrinogen, and serum lipids, Thrombosis and Haemostasis, 69, 1065
- Galan, 2008, The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics, Trials, 9, 35, 10.1186/1745-6215-9-35 · DOI
- Galan, 2009, The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and/or omega3 fatty acid supplements in the prevention of recurrent ischemic events, Sang Thrombose Vaisseaux, 21, 207
- Galan, 2009, The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and/or omega3 fatty acid supplements in the prevention of recurrent ischemic events, Sang Thrombose Vaisseaux, 21, 207
- McCormick, 2015, Peripheral sensory nerve function is independently associated with microvascular function, but neither are improved by n-3 fatty acids, Diabetic Medicine, 32, 99
- Scorletti, 2014, Potential benefits of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease (NAFLD): a potential treatment for early NAFLD in metabolic syndrome and type 2 diabetes? Results from the WELCOME study, Diabetic Medicine, 31, 1
- Baleztena Gurrea, 2015, Utility of heavy food supplement in omega-3 fatty acids in the prevention of dementia, in relation to the basal nutritional level, in people of advanced age: randomized multicenter study, Revista Española de Geriatría y Gerontología, 50, 1
- Bes-Rastrollo, 2015, Utility of a rich food supplement Omega-3 fatty acids in the prevention of dementia, in relation to baseline nutritional level, in people with advanced age: multicentre randomised study, Nutrición Clínica en Medicina, 9, 38
- Cheng, 1990, The effect of omega-3 fatty acids on restenosis after coronary angioplasty, European Heart Journal, 11, 368
- Fonolla, 2011, Daily intake of a low lactose dairy drink enriched with omega-3 (EPA+DHA), oleic acid and calcium improves nutritional and bone status in healthy postmenopausal women, Clinical Nutrition, 6, 86
- Franzen, 1989, Long-term effect of fish oil and olive oil on plasma lipids in patients with CHD, Zeitschrift fur Kardiologie, 78, 28
- Gapparova, 2000, Effects of omega-3 polyunsaturated fatty acids of vegetable and animal origin on clinical and metabolic indicators and the intensity of lipid peroxidation in patients with ischemic heart disease and impaired carbohydrate tolerance, Voprosy Pitaniia, 69, 46
- Hashimoto, 2011, Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function in elderly people with very mild dementia in Japan, Alzheimer's and Dementia, 1, S610
- Hashimoto, 2012, Beneficial effects of daily dietary omega-3 polyunsaturated fatty acid supplementation on age related cognitive decline in elderly Japanese with very mild dementia: a 2-year randomized,double-blind, placebo-controlled trial, Journal of Aging Research & Clinical Practice, 1, 193
- Lau, 1991, Effects of Maxepa on non-steroidal anti-inflammatory drug useage in patients with mild rheumatoid arthritis, British Journal of Rheumatology, 30, 137
- Lorgeril, 1999, Does a Mediterranean dietary pattern prolong survival?, Cardiology Review, 16, 30
- Mantzaris, 1996, A prospective, randomized, placebo-controlled study of fish oil in ulcerative colitis, Hellenic Journal of Gastroenterology, 9, 138
- Mate, 1991, Does dietary fish oil maintain the remission of Crohn's disease: a study case control, Gastroenterology, 100, A228
- Colquhoun, 1997, Rationale and design of the "OLIVE" study (comparison of an olive oil enriched to a low fat diet intervention study using vascular endpoints), Atheroscerosis, 134, 326
- Colquhoun, 1998, Comparison of an olive oil enriched diet to a low fat diet intervention study using vascular endpoints: assessed by repeat quantitative angiography (OLIVE study), Australian Journal of Nutrition and Dietetics, 55, S24
- Meilahn, 1990, Coagulation parameters among healthy adults taking fish oil versus placebo, Arteriosclerosis, 10, 916A
- Singh, 2012, Effect of low W-6/W-3 fatty acid ratio Paleolithic style diet in patients with acute coronary syndromes: a randomized, single blind, controlled trial, World Heart Journal, 4, 71
- Singh, 1997, Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival 4, Cardiovascular Drugs and Therapy, 11, 485, 10.1023/A:1007757724505 · DOI · Paper page
- Bowman, 2012, ASCEND: design and baseline characteristics of a large randomised trial in diabetes, Diabetes, 61, A556
- Chandrakala, 2012, Low-fat (< 20%) diets prevent type 2 diabetes mellitus, Diabetes, 61, A190
- Laake, 2014, Effects of omega 3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study, BMC Geriatrics, 14, 74, 10.1186/1471-2318-14-74 · DOI
- Shinto, 2015, Omega 3 fatty acids for the prevention of vascular cognitive aging: methods and rationale for a phase II trial, Alzheimer's & Dementia, 11, 610, 10.1016/j.jalz.2015.06.847 · DOI
- Gold, 2014, Baseline chronic obstructive pulmonary disease in the lung vitamin D and omega-3 trial, American Journal of Respiratory and Critical Care Medicine, 189, D44 COPD
- Kang, 2015, Cognitive substudy of the vitamin d and omega-3 trial (vital-cog): design of a large randomized trial of omega-3 and vitamin d supplements in relation to cognitive change, Alzheimer's & Dementia, 1, 608, 10.1016/j.jalz.2015.06.843 · DOI
- Manson, 2010, Vitamin D and cancer and cardiovascular disease: ready for prime time?, Menopause, 17, 1215
- Abdelhamid, 2017, Polyunsaturated fatty acids for musculoskeletal health and functional status in older adults, PROSPERO, www.crd.york.ac, CRD42017079211
- Hanson, 2017, Dietary polyunsaturated fat for prevention and treatment of depression and anxiety, PROSPERO, www.crd.york.ac, CRD42017056092
- Higgins JP Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Jimoh, 2017, Dietary polyunsaturated fat for prevention and treatment of neurocognitive disorders, PROSPERO, www.crd.york.ac, CRD42017019049
- Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Liem, 1997, Dioxins: Chemical Analysis, Exposure and Risk Assessment
- Mariani, 2013, N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials, Journal of the American Heart Association, 2, e005033, 10.1161/JAHA.112.005033 · DOI
- Thorpe, 2017, Dietary polyunsaturated fat for prevention and treatment of inflammatory bowel disease, PROSPERO, www.crd.york.ac, CRD42017068704
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811403 · Cited by 979
Metadata
- Authors
- Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., Song, F., & Hooper, L.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-07-18
- Volume
- 3
- Pages
- CD003177-CD003177
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2884415415
- Cited by
- 630
- References
- 483
- FWCI
- 65.32
- Type
- journal article
- Language
- en
- Update notices
- new_version (2018-11-30)
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.